Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |